Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q21098995> ?p ?o }
Showing triples 1 to 53 of
53
with 100 triples per page.
- Q21098995 subject Q52361.
- Q21098995 subject Q7310239.
- Q21098995 subject Q8256511.
- Q21098995 subject Q8758634.
- Q21098995 abstract "Evenamide (INN) (developmental code names NW-3509, NW-3509A) is a selective voltage-gated sodium channel blocker, including (and not limited to) subtypes Nav1.3, Nav1.7, and Nav1.8, that is described as an antipsychotic and is under development by Newron Pharmaceuticals as an add-on therapy for the treatment of schizophrenia. The drug has shown efficacy in animal models of psychosis, mania, depression, and aggression. It has completed phase I clinical trials, and phase II clinical trials will be commenced in the third quarter of 2015.[1]".
- Q21098995 atcPrefix "None".
- Q21098995 casNumber "1092977-61-1".
- Q21098995 iupacName "2-[2-(3-butoxyphenyl)ethylamino]-N,N-dimethylacetamide".
- Q21098995 pubchem "25105689".
- Q21098995 thumbnail Evenamide_structure.png?width=300.
- Q21098995 wikiPageExternalLink 800026870.
- Q21098995 wikiPageExternalLink newron-raised-new-funds-to-continue-the-development-of-neurological-therapies.
- Q21098995 wikiPageExternalLink Default.aspx?SEZ=3&PAG=44.
- Q21098995 wikiPageWikiLink Q1304270.
- Q21098995 wikiPageWikiLink Q14907685.
- Q21098995 wikiPageWikiLink Q170082.
- Q21098995 wikiPageWikiLink Q176301.
- Q21098995 wikiPageWikiLink Q18031397.
- Q21098995 wikiPageWikiLink Q18031401.
- Q21098995 wikiPageWikiLink Q185935.
- Q21098995 wikiPageWikiLink Q191797.
- Q21098995 wikiPageWikiLink Q208144.
- Q21098995 wikiPageWikiLink Q21098885.
- Q21098995 wikiPageWikiLink Q213907.
- Q21098995 wikiPageWikiLink Q219957.
- Q21098995 wikiPageWikiLink Q2211523.
- Q21098995 wikiPageWikiLink Q221174.
- Q21098995 wikiPageWikiLink Q30612.
- Q21098995 wikiPageWikiLink Q410346.
- Q21098995 wikiPageWikiLink Q410412.
- Q21098995 wikiPageWikiLink Q41112.
- Q21098995 wikiPageWikiLink Q420077.
- Q21098995 wikiPageWikiLink Q424960.
- Q21098995 wikiPageWikiLink Q4340209.
- Q21098995 wikiPageWikiLink Q52361.
- Q21098995 wikiPageWikiLink Q7180990.
- Q21098995 wikiPageWikiLink Q7310239.
- Q21098995 wikiPageWikiLink Q7553303.
- Q21098995 wikiPageWikiLink Q824258.
- Q21098995 wikiPageWikiLink Q8256511.
- Q21098995 wikiPageWikiLink Q8758634.
- Q21098995 atcPrefix "None".
- Q21098995 casNumber "1092977".
- Q21098995 iupacName "2".
- Q21098995 pubchem "25105689".
- Q21098995 type ChemicalSubstance.
- Q21098995 type Drug.
- Q21098995 type ChemicalObject.
- Q21098995 type Thing.
- Q21098995 type Q8386.
- Q21098995 comment "Evenamide (INN) (developmental code names NW-3509, NW-3509A) is a selective voltage-gated sodium channel blocker, including (and not limited to) subtypes Nav1.3, Nav1.7, and Nav1.8, that is described as an antipsychotic and is under development by Newron Pharmaceuticals as an add-on therapy for the treatment of schizophrenia. The drug has shown efficacy in animal models of psychosis, mania, depression, and aggression.".
- Q21098995 label "Evenamide".
- Q21098995 depiction Evenamide_structure.png.